Iglesias Juan Fernando
Clinical trials sponsored by Iglesias Juan Fernando, explained in plain language.
-
New stent combo aims to cut bleeding risk in High-Risk heart patients
Disease control Recruiting nowThis study tests a new ultra-thin stent coated with a drug to keep arteries open, combined with a shorter course of two blood thinners (1-3 months) followed by just one blood thinner, in people with left main coronary artery disease. The goal is to see if this approach reduces ma…
Phase: NA • Sponsor: IGLESIAS Juan Fernando • Aim: Disease control
Last updated Jun 16, 2026 12:51 UTC
-
Heart attack patients may soon skip aspirin after stenting
Disease control Recruiting nowThis study looks at 350 heart attack patients who get a special stent and then take only a strong blood thinner (no aspirin) for a year. The goal is to see if this approach lowers bleeding risk as much as the standard aspirin-plus-blood-thinner combo, while still preventing futur…
Phase: NA • Sponsor: IGLESIAS Juan Fernando • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New study aims to lower artery blockage risk in complex heart procedures
Disease control Recruiting nowThis study compares two ways to reach the heart through the wrist for complex procedures like opening blocked arteries. The goal is to see if using a more distant wrist point reduces the chance of blocking the main arm artery. About 708 adults needing these procedures will be ran…
Phase: NA • Sponsor: IGLESIAS Juan Fernando • Aim: Disease control
Last updated Jun 05, 2026 12:07 UTC